Label: MATE- altrenogest solution

  • NDC Code(s): 51072-119-00
  • Packager: Aurora Pharmaceutical, Inc.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated September 6, 2023

If you are a consumer or patient please visit this version.

  • DOSAGE FORMS & STRENGTHS

    2.2 mg/mL altrenogest

  • VETERINARY INDICATIONS

    For regulation and control of the breeding cycle of mares
    • To induce ovulatory oestrus early in the breeding season in mares where some follicular activity exists
    • For the suppression of oestrus either during prolonged oestrus or in normally cycling mares
    • For the control of the ovarian cycle in breeding mares to allow the most efficient use of the stallion

    For the maintenance of pregnancy in habitually aborting mares, or mares at risk of early embryonic death or abortion, where progesterone deficiency is thought to be the underlying cause.

  • CONTRAINDICATIONS

    Read the carton for full instruction

    DIRECTIONS FOR USE

    Restraints:
    DO NOT USE on male animals.

    Contraindications:
    Contraindicated for use in mares suffering from uterine infections.

    Precautions:
    Use with caution as unused feed must be destroyed and not given to any other animals.
    MATE must be added to the feed immediately prior to consumption and not stored.

  • Dosage and Administration:

    For oral administration.
    Administer 1 mL MATE per 50 kg bodyweight (equivalent to 0.044 mg altrenogest per kg) daily.
    1. Regulation and control of the breeding cycle of mares
    a. For the induction of ovulatory oestrus or to induce cyclical ovarian activity in mares with some follicle activity early in the breeding season: Administer MATE daily for 10 consecutive days.
    b. For the suppression of oestrus in normally cycling mares: Administer MATE daily for 15 consecutive days. For the suppression of prolonged oestrus: Administer MATE daily for 10 consecutive days.
    c. To control the breeding cycle of mares to allow efficient use of the stallion: Administer MATE daily for 15 consecutive days.
    2. For the treatment of habitually aborting mares, or mares at risk of early embryonic death or abortion: Administer MATE daily, from the 2nd or 3rd day after ovulation in the mated or inseminated mare, continuing until day 120 of gestation.

    NOTE: Ultrasound scanning to confirm pregnancy is recommended on day 14 or 15 after ovulation. If the mare is not pregnant, it is advised to cease MATE administration and to administer an injection of prostaglandin F2α to destroy any luteal tissue that may be still present, allowing the mare to return to oestrus and be re-mated.

    MEAT WITHHOLDING PERIODS (HORSES)

    DO NOT USE less than 28 days before slaughter for human consumption.

  • SAFETY DIRECTIONS

    Product is harmful if absorbed by skin contact, inhaled or swallowed. Avoid contact with eyes and skin. Do not inhale. When using the product wear rubber gloves. After use and before eating, drinking or smoking, wash hands, arms and face thoroughly with soap and water. After each day's use, wash gloves. Care should be taken to avoid contact between the solution and women of child bearing age.

    FIRST AID INSTRUCTIONS
    If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 13 11 26.

    ADDITIONAL USER SAFETY INFORMATION
    Additional information is listed in the safety data sheet (SDS).

  • STORAGE

    Store below 25°C (air conditioning). Protect from light.

  • SPL UNCLASSIFIED SECTION

    Manufactured by:
    Aurora Pharmaceutical, Inc.

    Distributed by:
    South Yarra Pharma Pty Ltd
    27-33 Piper Line, East Bendigo VIC 3550
    Australia
    Call Toll-free: 1800 426 142

    APVMA Approval No.: 92068/134364

  • PRINCIPAL DISPLAY PANEL

    PRINCIPAL DISPLAY PANEL - 1000 mL bottle label

    IN 50-1715 06/2023

    1L Bottle label

  • INGREDIENTS AND APPEARANCE
    MATE 
    altrenogest solution
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:51072-119
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ALTRENOGEST (UNII: 2U0X0JA2NB) (ALTRENOGEST - UNII:2U0X0JA2NB) ALTRENOGEST2.2 mg  in 1 mL
    Product Characteristics
    Coloryellow (colorless to yellow) Score    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51072-119-001000 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    export only09/01/2023
    Labeler - Aurora Pharmaceutical, Inc. (832848639)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aurora Pharmaceutical, Inc.832848639manufacture